These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37288156)

  • 61. Bisphosphonate-treatment of secondary chronic osteomyelitis of the jaw - a case report.
    Heimes D; Kämmerer PW
    J Surg Case Rep; 2023 May; 2023(5):rjad270. PubMed ID: 37251250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.
    You Tm; Lee KH; Lee SH; Park W
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):548-53. PubMed ID: 26337218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
    Khan AA; Morrison A; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL; Taguchi A; Tetradis S; Watts NB; Brandi ML; Peters E; Guise T; Eastell R; Cheung AM; Morin SN; Masri B; Cooper C; Morgan SL; Obermayer-Pietsch B; Langdahl BL; Al Dabagh R; Davison KS; Kendler DL; Sándor GK; Josse RG; Bhandari M; El Rabbany M; Pierroz DD; Sulimani R; Saunders DP; Brown JP; Compston J;
    J Bone Miner Res; 2015 Jan; 30(1):3-23. PubMed ID: 25414052
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis.
    Ohga N; Yamazaki Y; Tsuboi K; Kitagawa Y
    Quintessence Int; 2015; 46(7):621-6. PubMed ID: 25646168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diffuse sclerosing osteomyelitis in the maxilla: case report.
    Cebeci AR; Kamburoğlu K; Oztaş B
    Dent Update; 2004 Sep; 31(7):405-6, 409. PubMed ID: 15485122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
    Body JJ; von Moos R; Niepel D; Tombal B
    BMC Urol; 2018 Sep; 18(1):81. PubMed ID: 30236112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature.
    Ikuta K; Sakai T; Koike H; Ito K; Imagama S; Nishida Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28138. PubMed ID: 34889277
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
    Mok CC; Ho LY; Ma KM
    Bone; 2015 Jun; 75():222-8. PubMed ID: 25761434
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic possibilities of long-term roxithromycin treatment for chronic diffuse sclerosing osteomyelitis of the mandible.
    Yoshii T; Nishimura H; Yoshikawa T; Furudoi S; Yoshioka A; Takenono I; Ohtsuka Y; Komori T
    J Antimicrob Chemother; 2001 May; 47(5):631-7. PubMed ID: 11328775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study.
    Clemens KK; Jeyakumar N; Ouédraogo AM; Thain J; Khan T
    Arch Osteoporos; 2020 Aug; 15(1):133. PubMed ID: 32816151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Denosumab-related osteonecrosis of the jaw.
    Diz P; López-Cedrún JL; Arenaz J; Scully C
    J Am Dent Assoc; 2012 Sep; 143(9):981-4. PubMed ID: 22942143
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
    Hanley DA; McClung MR; Davison KS; Dian L; Harris ST; Miller PD; Lewiecki EM; Kendler DL;
    Am J Med; 2017 Jul; 130(7):862.e1-862.e7. PubMed ID: 28359721
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review.
    Hendriks LE; Hermans BC; van den Beuken-van Everdingen MH; Hochstenbag MM; Dingemans AM
    J Thorac Oncol; 2016 Feb; 11(2):155-73. PubMed ID: 26718881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Diffuse sclerosing osteomyelitis--a review and case].
    Uglesić V; Bagatin M
    Acta Stomatol Croat; 1988; 22(4):297-304. PubMed ID: 3076350
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis.
    Bozzo A; Deng J; Abbas U; Bhasin R; Deodat M; Wariach S; Sanger S; Axelrod D; Masrouha K; Turcotte R; Wilson D; Ghert M
    Clin Orthop Relat Res; 2021 Sep; 479(9):2047-2057. PubMed ID: 33835092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients.
    Morizio P; Burkhart JI; Ozawa S
    Ann Pharmacother; 2018 Oct; 52(10):1031-1041. PubMed ID: 29616561
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report.
    Urade M; Noguchi K; Takaoka K; Moridera K; Kishimoto H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):e9-12. PubMed ID: 22771405
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences between florid osseous dysplasia and chronic diffuse sclerosing osteomyelitis.
    Schneider LC; Mesa ML
    Oral Surg Oral Med Oral Pathol; 1990 Sep; 70(3):308-12. PubMed ID: 2216358
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible.
    Soubrier M; Dubost JJ; Ristori JM; Sauvezie B; Bussière JL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):637-40. PubMed ID: 11740481
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Denosumab Use in Adults With Fibrous Dysplasia: Case Reports and Review of the Literature.
    Hung C; Shibli-Rahhal A
    Endocr Pract; 2022 Nov; 28(11):1196-1201. PubMed ID: 35952985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.